Microfluidics: the propellant of CRISPR-based nucleic acid detection

Trends Biotechnol. 2023 Apr;41(4):557-574. doi: 10.1016/j.tibtech.2022.07.015. Epub 2022 Aug 18.

Abstract

Since the discovery of collateral cleavage activity, clustered regularly interspaced short palindromic repeats (CRISPR)/Cas systems have become the new generation of nucleic acid detection tools. However, their widespread application remains limited. A pre-amplification step is required to improve the sensitivity of CRISPR systems, complicating the operating procedure and limiting quantitative precision. In addition, nonspecific collateral cleavage activity makes it difficult to realize multiplex detection in a one-pot CRISPR reaction with a single Cas protein. Microfluidics, which can transfer nucleic acid analysis process to a chip, has the advantages of miniaturization, integration, and automation. Microfluidics coupled with CRISPR systems improves the detection ability of CRISPR, enabling fast, high-throughput, integrated, multiplex, and digital detection, which results in the further popularization of CRISPR for a range of scenarios.

Keywords: CRISPR; digitalization; integration; microfluidics; multiplexing; nucleic acid detection.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CRISPR-Cas Systems*
  • Microfluidics
  • Nucleic Acids* / genetics

Substances

  • Nucleic Acids